Document is current
Any future updates will be listed below
-
Authors
Brummer, Otso
Pölönen, Petri
Mustjoki, Satu https://orcid.org/0000-0002-0816-8241
Brück, Oscar https://orcid.org/0000-0002-7842-9419
- License Information
-
More Information
Article History
Received: 26 October 2022
Revised: 18 May 2023
Accepted: 14 June 2023
First Online: 30 June 2023
Competing interests
: O Brummer and PP declare no competing financial or non-financial interests. SM declares no competing non-financial interests but the following competing financial interests: research funding from Pfizer, Novartis, Janpix, and Bristol-Myers Squibb, outside the submitted work. O Brück declares no competing non-financial interests but the following competing financial interests: consultancy fees from Novartis, Sanofi, Pfizer, and Amgen, outside the submitted work.
: The study complied with the Declaration of Helsinki. TCGA analyses are permitted based on their ethical statement . The Helsinki dataset has been analysed with an approval of the Helsinki University Hospital ethics committee.
